Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Osteoporosis

Free Subscription Articles published in Ann Intern Med Retrieve available abstracts of 19 articles: HTML format

Single Articles

September 2026
1. CHOU R, Ahmed AY, Hart EL, Totten AM, et al
   Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians (Version 1: Update Alert 2).
   Ann Intern Med. 2026 Sep 8. doi: 10.7326/ANNALS-26-02845.
   PubMed    
   
   
   
2. QASEEM A, Mackey K, Shamliyan TA, Cross JT Jr, et al
   Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians (Version 1: Update Alert 2).
   Ann Intern Med. 2026 Sep 8. doi: 10.7326/ANNALS-26-02740.
   PubMed    
   
   
   
3. LIM LS
   In men with osteoporosis/osteopenia, denosumab, alendronate, and zoledronic acid did not differ for lumbar spine BMD at 12 mo.
   Ann Intern Med. 2026 Sep 1. doi: 10.7326/ANNALS-26-03037.
   PubMed     Abstract available
   
   
   May 2026
4. HUANG YQ, Watt J
   In postmenopausal women at high risk for fracture, romosozumab for 3 mo was noninferior to 12 mo for increasing total hip BMD at 1 y.
   Ann Intern Med. 2026;179:JC52.
   PubMed     Abstract available
   
   
   December 2025
5. FERRARO MC, O'Connell NE, Goebel A, Hill R, et al
   Efficacy and Safety of Bisphosphonates for Complex Regional Pain Syndrome : A Systematic Review and Meta-analysis.
   Ann Intern Med. 2025 Dec 16. doi: 10.7326/ANNALS-25-03693.
   PubMed     Abstract available
   
   
   
6. 
   Annals Video Summary - Efficacy and Safety of Bisphosphonates for Complex Regional Pain Syndrome: A Systematic Review and Meta-analysis.
   Ann Intern Med. 2025 Dec 16:e2504827VS. doi: 10.7326/ANNALS-25-04827.
   PubMed    
   
   
   May 2025
7. HUANG YQ, Watt J
   In early postmenopausal women, zoledronate vs. placebo at baseline and 5 y reduced morphometric vertebral fractures at 10 y.
   Ann Intern Med. 2025 May 6. doi: 10.7326/ANNALS-25-01103.
   PubMed     Abstract available
   
   
   April 2025
8. LIBMAN H, Yu EW, Malabanan AO, Smetana GW, et al
   How Would You Manage This Patient With Decreased Bone Density? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
   Ann Intern Med. 2025 Apr 8. doi: 10.7326/ANNALS-25-00474.
   PubMed     Abstract available
   
   
   February 2025
9. AYERS CK, Kansagara D
   Surveillance Note: Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians.
   Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-03552.
   PubMed    
   
   
   
10. QASEEM A, Cooney TG, Shamliyan TA, Yost J, et al
    Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians (Version 1: Update Alert 1: Surveillance Note 1).
    Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-03547.
    PubMed    
    
    
    January 2025
11. MASUDA S, Fukasawa T, Matsuda S, Kawakami K, et al
    Cardiovascular Safety and Fracture Prevention Effectiveness of Denosumab Versus Oral Bisphosphonates in Patients Receiving Dialysis : A Target Trial Emulation.
    Ann Intern Med. 2025 Jan 7. doi: 10.7326/ANNALS-24-03237.
    PubMed     Abstract available
    
    
    November 2024
12. BIRD ST, Gelperin K, Smith ER, Jung TH, et al
    The Effect of Denosumab on Risk for Emergently Treated Hypocalcemia by Stage of Chronic Kidney Disease : A Target Trial Emulation.
    Ann Intern Med. 2024 Nov 19. doi: 10.7326/M24-0013.
    PubMed     Abstract available
    
    
    May 2024
13. AYERS C, Ward R, Kansagara D
    Update Alert: Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians.
    Ann Intern Med. 2024 May 7. doi: 10.7326/L24-0118.
    PubMed    
    
    
    
14. QASEEM A, Hicks LA, Etxeandia-Ikobaltzeta I, Shamliyan TA, et al
    Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians (Version 1, Update Alert).
    Ann Intern Med. 2024 May 7. doi: 10.7326/L24-0113.
    PubMed    
    
    
    
15. JALALI K, Mandl LA
    Rheumatology: What You May Have Missed in 2023.
    Ann Intern Med. 2024;177.
    PubMed     Abstract available
    
    
    January 2024
16. ENSRUD KE, Crandall CJ
    Osteoporosis.
    Ann Intern Med. 2024 Jan 9. doi: 10.7326/AITC202401160.
    PubMed     Abstract available
    
    
    October 2023
17. QASEEM A, Mount CA, Campos K, McLean RM, et al
    Quality Indicators for Osteoporosis in Adults: A Review of Performance Measures by the American College of Physicians.
    Ann Intern Med. 2023 Oct 3. doi: 10.7326/M23-1291.
    PubMed     Abstract available
    
    
    May 2023
18. 
    Correction: Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults.
    Ann Intern Med. 2023 May 16. doi: 10.7326/L23-0120.
    PubMed    
    
    
    
19. 
    Correction: Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis.
    Ann Intern Med. 2023 May 16. doi: 10.7326/L23-0105.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum